Clinical Trial: A Study to Assess the Safety of ARGX-124 in Healthy Volunteers

U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07377396) titled 'A Study to Assess the Safety of ARGX-124 in Healthy Volunteers' on Jan. 22.

Brief Summary: This study aims to assess the safety of ARGX-124 in healthy adults. Another aim is to measure the amount of ARGX-124 in the blood over time to learn how it acts and moves in the body and how the immune system responds to it. Participants will remain in the study for up to approximately 23 weeks.

Study Start Date: Jan. 23

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: BIOLOGICAL: ARGX-124

Administrations of ARGX-124

OTHER: Placebo

Administrations of placebo comparator

Recruitment Status: NOT_YET_RECRUITING

Spo...